Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy

JAMA Dermatol. 2018 Mar 1;154(3):370-371. doi: 10.1001/jamadermatol.2017.5778.

Authors

Sa Rang Kim¹, Henry Heaton¹, Lucy Y Liu¹, Brett A King¹

Affiliation

¹ Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut.

PMID: 29387870
DOI: 10.1001/jamadermatol.2017.5778

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Combined Modality Therapy
Female
Humans
Male
Middle Aged
Piperidines / therapeutic use*
Protein Kinase Inhibitors / therapeutic use*
Pyrimidines / therapeutic use*
Pyrroles / therapeutic use*
Skin Pigmentation* / drug effects
Skin Pigmentation* / radiation effects
Ultraviolet Therapy*
Vitiligo / therapy*

Substances

Piperidines
Protein Kinase Inhibitors
Pyrimidines
Pyrroles
tofacitinib